Wyeth Taps Pharmacopeia Technology For Potential Small Molecule RA Therapies
The two firms will each develop and commercialize products resulting from research based on Pharmacopeia’s JAK3 inhibitor program.
The two firms will each develop and commercialize products resulting from research based on Pharmacopeia’s JAK3 inhibitor program.